Peter Wells
Director/Board Member at Novavax AB
Profile
Peter Wells is currently a Director at Novavax AB and a Director at Global Alliance for Livestock Veterinary Medicines.
He previously worked as a Director at The Moredun Foundation, Jenner Vaccine Foundation, and Elanco Tiergesundheit AG.
Dr. Wells holds a doctorate degree from The University of Nottingham.
Peter Wells active positions
| Companies | Position | Start |
|---|---|---|
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Director/Board Member | 2009-08-03 |
Global Alliance for Livestock Veterinary Medicines
 Global Alliance for Livestock Veterinary Medicines Miscellaneous Commercial ServicesCommercial Services The Global Alliance for Livestock Veterinary Medicines provides social services. The CEO of the British company is Peter Jeffries. | Director/Board Member | - |
Former positions of Peter Wells
| Companies | Position | End |
|---|---|---|
Elanco Tiergesundheit AG
 Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | - |
| The Moredun Foundation | Director/Board Member | - |
| Jenner Vaccine Foundation | Director/Board Member | - |
Training of Peter Wells
| The University of Nottingham | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Health Technology |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
| The Moredun Foundation | Miscellaneous |
| Jenner Vaccine Foundation | |
Global Alliance for Livestock Veterinary Medicines
Global Alliance for Livestock Veterinary Medicines Miscellaneous Commercial ServicesCommercial Services The Global Alliance for Livestock Veterinary Medicines provides social services. The CEO of the British company is Peter Jeffries. | Commercial Services |
- Stock Market
- Insiders
- Peter Wells
